{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:08:15Z","timestamp":1783019295058,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["DEC-2013\/09\/N\/NZ4\/02045"],"award-info":[{"award-number":["DEC-2013\/09\/N\/NZ4\/02045"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["DEC-2016\/20\/T\/NZ3\/00504"],"award-info":[{"award-number":["DEC-2016\/20\/T\/NZ3\/00504"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.pharep.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:18:58Z","timestamp":1529453938000},"page":"1010-1014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Sphingosine kinase 1\/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-9732","authenticated-orcid":false,"given":"Joanna","family":"Motyl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna B.","family":"Strosznajder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"5","key":"10.1016\/j.pharep.2018.05.002_bib0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ane.12563","article-title":"The genetic background of Parkinson\u2019s disease: current progress and future prospects","volume":"134","author":"Kalinderi","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.pharep.2018.05.002_bib0010","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","article-title":"Neurodegeneration and inflammation in parkinson\u2019s disease","volume":"18","author":"Phani","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.pharep.2018.05.002_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2016.13","article-title":"A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration","volume":"17","author":"Walsh","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"Pt. B","key":"10.1016\/j.pharep.2018.05.002_bib0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases","volume":"113","author":"O\u2019Sullivan","year":"2017","journal-title":"Neuropharmacology"},{"issue":"24","key":"10.1016\/j.pharep.2018.05.002_bib0025","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","article-title":"Essential role for sphingosine kinases in neural and vascular development essential role for sphingosine kinases in neural and vascular development","volume":"25","author":"Mizugishi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharep.2018.05.002_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2051-5960-2-9","article-title":"Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer\u2019s disease pathogenesis","volume":"2","author":"Couttas","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.pharep.2018.05.002_bib0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.pharep.2018.05.002_bib0040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuroscience.2004.08.056","article-title":"Astroglial expression of ceramide in Alzheimer\u2019s disease brains: a role during neuronal apoptosis","volume":"130","author":"Satoi","year":"2005","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pharep.2018.05.002_bib0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11064-014-1240-3","article-title":"Sphingosine kinases\/Sphingosine-1-Phosphate and death signalling in APP-transfected cells","volume":"39","author":"Gassowska","year":"2014","journal-title":"Neurochem Res"},{"issue":"9","key":"10.1016\/j.pharep.2018.05.002_bib0050","doi-asserted-by":"crossref","first-page":"e0137193","DOI":"10.1371\/journal.pone.0137193","article-title":"The molecular mechanism of amyloid \u03b242 peptide toxicity: the role of sphingosine kinase-1 and mitochondrial sirtuins","volume":"10","author":"Cie\u015blik","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharep.2018.05.002_bib0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11596-013-1136-5","article-title":"Effects of small interfering RNA targeting sphingosine kinase-1 gene on the animal model of Alzheimer\u2019s disease","volume":"33","author":"Zhang","year":"2013","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"10.1016\/j.pharep.2018.05.002_bib0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fncel.2014.00283","article-title":"Fingolimod for the treatment of neurological diseases-state of play and future perspectives","volume":"8","author":"Brunkhorst","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.pharep.2018.05.002_bib0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cen3.12397","article-title":"Neurological safety of fingolimod: an updated review","volume":"8","author":"Yoshii","year":"2017","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.pharep.2018.05.002_bib0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neuroscience.2015.01.032","article-title":"Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson\u2019s disease and in MPP+ \u2212treated MN9D cells in vitro","volume":"290","author":"Sivasubramanian","year":"2015","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharep.2018.05.002_bib0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5114\/fn.2014.45567","article-title":"The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson\u2019s disease","volume":"52","author":"Pyszko","year":"2014","journal-title":"Folia Neuropathol"},{"issue":"1","key":"10.1016\/j.pharep.2018.05.002_bib0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12035-013-8622-4","article-title":"Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells","volume":"50","author":"Pyszko","year":"2014","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.pharep.2018.05.002_bib0085","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","article-title":"FTY720 attenuates 6-OHDA-associated dopaminergic degeneration in cellular and mouse parkinsonian models","volume":"42","author":"Ren","year":"2017","journal-title":"Neurochem Res"},{"issue":"7","key":"10.1016\/j.pharep.2018.05.002_bib0090","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/ml500128g","article-title":"Novel FTY720-based compounds stimulate neurotrophin expression and phosphatase activity in dopaminergic cells","volume":"5","author":"Vargas-Medrano","year":"2014","journal-title":"ACS Med Chem Lett"},{"issue":"39","key":"10.1016\/j.pharep.2018.05.002_bib0095","doi-asserted-by":"crossref","first-page":"20811","DOI":"10.1074\/jbc.M116.744029","article-title":"FTY720\/Fingolimod reduces synucleinopathy and improves gut motility in A53T mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF","volume":"291","author":"Vidal-Mart\u00ednez","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2018.05.002_bib0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson\u2019s disease by activation of sphingosine kinase 1 and Akt kinase","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2018.05.002_bib0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1096\/fj.201600751R","article-title":"Neuroprotective effects of fingolimod in mouse models of Parkinson\u2019s disease","volume":"31","author":"Zhao","year":"2017","journal-title":"FASEB J"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017306990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017306990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:40Z","timestamp":1752611860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.05.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1734114017306990"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.05.002","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosine kinase 1\/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}